INCEL

Serial Number 75315645
601

Registration Progress

Application Filed
Jun 26, 1997
Under Examination
Oct 22, 2002
Approved for Publication
Jul 10, 2002
Published for Opposition
Jul 30, 2002
Registered

Basic Information

Serial Number
75315645
Filing Date
June 26, 1997
Published for Opposition
July 30, 2002
Abandonment Date
October 24, 2005
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Oct 24, 2005
Classes
005

Rights Holder

Vertex Pharmaceuticals Incorporated

03
Address
130 Waverly Street
Cambridge, MA 021394242

Quick Actions

Search by Rights Holder Search by Attorney Search by Status Code 601

Ownership History

Vertex Pharmaceuticals Incorporated

Original Applicant
03
Cambridge, MA

Vertex Pharmaceuticals Incorporated

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
LISA M TITTEMORE
USPTO Deadlines 1 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication 		NPUBO Aug 09, 2002 8368 days overdue Medium Until Sep 09, 2002

Application History

29 events
Date Code Type Description
Nov 4, 2005 MAB1 O ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Oct 26, 2005 MAIL I PAPER RECEIVED
Oct 24, 2005 ABN1 S ABANDONMENT - EXPRESS MAILED
Apr 25, 2005 MAIL I PAPER RECEIVED
Apr 21, 2005 EXT5 S SOU EXTENSION 5 FILED
Apr 21, 2005 EX5G S SOU EXTENSION 5 GRANTED
Oct 26, 2004 MAIL I PAPER RECEIVED
Oct 21, 2004 EXT4 S SOU EXTENSION 4 FILED
Oct 21, 2004 EX4G S SOU EXTENSION 4 GRANTED
May 6, 2004 CFIT O CASE FILE IN TICRS
Apr 23, 2004 MAIL I PAPER RECEIVED
Apr 21, 2004 EXT3 S SOU EXTENSION 3 FILED
Apr 21, 2004 EX3G S SOU EXTENSION 3 GRANTED
Nov 19, 2003 EX2G S SOU EXTENSION 2 GRANTED
Oct 23, 2003 MAIL I PAPER RECEIVED
Oct 20, 2003 EXT2 S SOU EXTENSION 2 FILED
Jun 3, 2003 EX1G S SOU EXTENSION 1 GRANTED
Apr 16, 2003 MAIL I PAPER RECEIVED
Apr 16, 2003 EXT1 S SOU EXTENSION 1 FILED
Oct 22, 2002 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 30, 2002 PUBO A PUBLISHED FOR OPPOSITION
Jul 10, 2002 NPUB O NOTICE OF PUBLICATION
Mar 15, 2002 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2000 CNSL F LETTER OF SUSPENSION MAILED
Nov 6, 1999 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 1998 CNSL F LETTER OF SUSPENSION MAILED
Feb 13, 1998 DOCK D ASSIGNED TO EXAMINER
Feb 2, 1998 DOCK D ASSIGNED TO EXAMINER
Jan 28, 1998 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
pharmaceutical preparations, namely, cancer multi-drug resistance inhibitors
First Use Anywhere: 0
First Use in Commerce: 0

Active Deadlines

Notice of Publication
Due: Aug 09, 2002 Overdue

Classification

International Classes
005